Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at two upcoming investor conferences:

Bank Of America Securities 2023 Health Care ConferenceTuesday, May 9, 2023 at 2:20 p.m. PT. (5:20 p.m. ET.)

2023 RBC Capital Markets Global Healthcare ConferenceWednesday, May 17, 2023 at 10:30 a.m. ET.

A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Cameron Radinovic[email protected]212-213-0006

Source: Intra-Cellular Therapies Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alphabet taps bond market with sweeping 10-part offering to fuel AI ambitions
• Transaction in Own Shares
• Baltic Horizon Fund consolidated unaudited results for Q2 2026